Real world evidence of the efficacy of two hybrid closed loop systems for children and adults with type 1 diabetes with some clinical warnings

Diabetes Metab. 2022 Nov;48(6):101396. doi: 10.1016/j.diabet.2022.101396. Epub 2022 Oct 14.

Authors

Z Henry¹, S Villar Fimbel¹, N Bendelac¹, C Thivolet²

Affiliations

¹ DIAB-eCARE, Center for Diabetes, Hospices Civils de Lyon, 60 Avenue Rockefeller, Lyon 69008, France.
² DIAB-eCARE, Center for Diabetes, Hospices Civils de Lyon, 60 Avenue Rockefeller, Lyon 69008, France. Electronic address: [email protected].

PMID: 36252880
DOI: 10.1016/j.diabet.2022.101396

No abstract available

Publication types

Letter

MeSH terms

Adult
Blood Glucose
Blood Glucose Self-Monitoring
Child
Diabetes Mellitus, Type 1* / drug therapy
Humans
Hypoglycemic Agents / therapeutic use
Insulin / therapeutic use
Insulin Infusion Systems
Pancreas, Artificial*

Substances

Insulin
Blood Glucose
Hypoglycemic Agents